Providence cancer researcher earns two-year award

November 07, 2011
William Redmond, Ph.D., recently received the 2011 V Scholar Award from The V Foundation for Cancer Research. During the two years of the $200,000 award, Dr. Redmond will investigate the cellular and molecular mechanisms by which anti-OX40 therapy in the presence of CTLA-4 blockade augments tumor immunotherapy. His research also examines the role of microRNAs in regulating this process.

The goal of these studies is to identify new avenues of investigation and additional therapeutic targets and, ultimately, to translate these findings into the clinic to directly benefit patients. Dr. Redmond, who heads a research laboratory at the Robert W. Franz Cancer Research Center in the Earle A. Chiles Institute at Providence Cancer Center, also received a four-year, $1.2 million research award from the National Institutes of Health in 2010.

The V Foundation was established by ESPN and Jim Valvano in 1993 to help find a cure for cancer. It has raised more than $100 million and funded more than 400 research and awareness grants.